Possibly, but it should be considered that the sophisticated technology currently used to look at viral insertions into the human genome did not exist at the time, and that the wealth of information now available on the subject would not exist had those adverse events never occurred.
Think about the timing of your tricks, the main aspect of crossing a defender is when to start the trick and where it will end at, and possibly which direction it should be going at.
An accompanying discussion must then also deal with how this can be recognized, what this can possibly mean, and how it should be used, if at all.
Think about it: at the cost of possibly $2 trillion since 9/11, it should be one of the stories of the century.
Possibly flawed, but never coerced, it should be a valued, curricular option.
It is as if a directive had come down from on high — hmm, that might actually explain this one — saying that if any group of concerts can possibly be called a festival, it should be.
In the presence of anti-DFS70 antibodies (possibly confirmed with specific tests), it should be indicated that said marker "does not generally correlate with ANA-associated autoimmune pathology".
And we always leave with a trolley fuller than it should be, and possibly more bags of flour than I'd ever need.
Firstly we consider the simple case where a variable of interest has been pre-specified and one wants to know in which of the sub-models it should be included, possibly in order to investigate mechanistic hypotheses.
This suggests constraint in terms of clearing the species barrier to transmit efficiently in humans (or possibly a cost to resistance, although it should be noted that this has not impeded the emergence of numerous community acquired MRSA clones from nonlivestock sources).
